Blue Crest Capital Management LTD Rocket Pharmaceuticals, Inc. Transaction History

Blue Crest Capital Management LTD

  • $3.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$11.21 - $23.53 $99,769 - $209,417
-8,900 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$18.5 - $25.49 $164,650 - $226,861
8,900 New
8,900 $219,000
Q2 2018

Aug 14, 2018
SELL
$14.58 - $23.0 $866,868 - $1.37 Million
-59,456 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$11.68 - $19.19 $694,446 - $1.14 Million
59,456 New
59,456 $1.12 Million

Others Institutions Holding RCKT

# of Institutions
244
Shares Held
108M
Call Options Held
262K
Put Options Held
159K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $664M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email